Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

T-cell recognition of chemicals, protein allergens and drugs: towards the development of in vitro assays.

Martin SF, Esser PR, Schmucker S, Dietz L, Naisbitt DJ, Park BK, Vocanson M, Nicolas JF, Keller M, Pichler WJ, Peiser M, Luch A, Wanner R, Maggi E, Cavani A, Rustemeyer T, Richter A, Thierse HJ, Sallusto F.

Cell Mol Life Sci. 2010 Dec;67(24):4171-84. doi: 10.1007/s00018-010-0495-3. Epub 2010 Aug 18. Review.

PMID:
20717835
2.
3.

Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).

Lilienblum W, Dekant W, Foth H, Gebel T, Hengstler JG, Kahl R, Kramer PJ, Schweinfurth H, Wollin KM.

Arch Toxicol. 2008 Apr;82(4):211-36. doi: 10.1007/s00204-008-0279-9. Epub 2008 Mar 6.

PMID:
18322675
4.

In vitro detection of contact allergens: development of an optimized protocol using human peripheral blood monocyte-derived dendritic cells.

Reuter H, Spieker J, Gerlach S, Engels U, Pape W, Kolbe L, Schmucker R, Wenck H, Diembeck W, Wittern KP, Reisinger K, Schepky AG.

Toxicol In Vitro. 2011 Feb;25(1):315-23. doi: 10.1016/j.tiv.2010.09.016. Epub 2010 Oct 29.

PMID:
20932890
5.

Interactions of contact allergens with dendritic cells: opportunities and challenges for the development of novel approaches to hazard assessment.

Ryan CA, Gerberick GF, Gildea LA, Hulette BC, Betts CJ, Cumberbatch M, Dearman RJ, Kimber I.

Toxicol Sci. 2005 Nov;88(1):4-11. Epub 2005 Jul 13. Review.

PMID:
16014741
6.

Approaches for the development of cell-based in vitro methods for contact sensitization.

Ryan CA, Hulette BC, Gerberick GF.

Toxicol In Vitro. 2001 Feb;15(1):43-55. Review.

PMID:
11259869
7.

In vitro and in vivo analysis of pro- and anti-inflammatory effects of weak and strong contact allergens.

Lass C, Merfort I, Martin SF.

Exp Dermatol. 2010 Nov;19(11):1007-13. doi: 10.1111/j.1600-0625.2010.01136.x.

8.

Mechanistic assessment of peptide reactivity assay to predict skin allergens with Kathon CG isothiazolinones.

Mutschler J, Giménez-Arnau E, Foertsch L, Gerberick GF, Lepoittevin JP.

Toxicol In Vitro. 2009 Apr;23(3):439-46.

PMID:
19444925
9.

Skin sensitisation: the Colipa strategy for developing and evaluating non-animal test methods for risk assessment.

Maxwell G, Aeby P, Ashikaga T, Bessou-Touya S, Diembeck W, Gerberick F, Kern P, Marrec-Fairley M, Ovigne JM, Sakaguchi H, Schroeder K, Tailhardat M, Teissier S, Winkler P.

ALTEX. 2011;28(1):50-5.

10.

Progress on the development of human in vitro dendritic cell based assays for assessment of the sensitizing potential of a compound.

dos Santos GG, Reinders J, Ouwehand K, Rustemeyer T, Scheper RJ, Gibbs S.

Toxicol Appl Pharmacol. 2009 May 1;236(3):372-82. doi: 10.1016/j.taap.2009.02.004. Epub 2009 Feb 14. Review.

PMID:
19232364
11.

Hapten-protein binding: from theory to practical application in the in vitro prediction of skin sensitization.

Divkovic M, Pease CK, Gerberick GF, Basketter DA.

Contact Dermatitis. 2005 Oct;53(4):189-200. Review.

PMID:
16191014
12.

Putting the parts together: combining in vitro methods to test for skin sensitizing potentials.

Bauch C, Kolle SN, Ramirez T, Eltze T, Fabian E, Mehling A, Teubner W, van Ravenzwaay B, Landsiedel R.

Regul Toxicol Pharmacol. 2012 Aug;63(3):489-504. doi: 10.1016/j.yrtph.2012.05.013. Epub 2012 Jun 1. Erratum in: Regul Toxicol Pharmacol. 2012 Nov;64(2):285.

PMID:
22659254
13.

[Assessment of the sensitizing potency of cosmetic ingredients and commodities. How will the ingredients of cosmetics and commodities be tested in Europe today and tomorrow?].

Peiser M, Platzek T, Luch A.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2012 Mar;55(3):373-9. doi: 10.1007/s00103-011-1435-6. Review. German.

PMID:
22373851
14.

New aspects in allergic contact dermatitis.

Mortz CG, Andersen KE.

Curr Opin Allergy Clin Immunol. 2008 Oct;8(5):428-32. doi: 10.1097/ACI.0b013e32830d84ec. Review.

PMID:
18769196
16.

Intralaboratory validation of four in vitro assays for the prediction of the skin sensitizing potential of chemicals.

Bauch C, Kolle SN, Fabian E, Pachel C, Ramirez T, Wiench B, Wruck CJ, van Ravenzwaay B, Landsiedel R.

Toxicol In Vitro. 2011 Sep;25(6):1162-8. doi: 10.1016/j.tiv.2011.05.030. Epub 2011 Jun 7.

PMID:
21669280
17.

Human T cell priming assay (hTCPA) for the identification of contact allergens based on naive T cells and DC--IFN-γ and TNF-α readout.

Richter A, Schmucker SS, Esser PR, Traska V, Weber V, Dietz L, Thierse HJ, Pennino D, Cavani A, Martin SF.

Toxicol In Vitro. 2013 Apr;27(3):1180-5. doi: 10.1016/j.tiv.2012.08.007. Epub 2012 Aug 11.

PMID:
22906571
18.

[Irritant contact dermatitis. Part II. Evaluation evaluation of skin irritation potential of chemicals].

Chomiczewska D, Kieć-Swierczyńska M, Krecisz B.

Med Pr. 2009;60(3):209-14. Review. Polish.

PMID:
19746889
19.

Reduction, refinement and replacement: putting the immune system to work.

Kimber I.

Altern Lab Anim. 2002 Nov-Dec;30(6):569-77.

PMID:
12511192
20.

Immune responses to contact allergens: novel approaches to hazard evaluation.

Kimber I, Pichowski JS, Basketter DA, Dearman RJ.

Toxicol Lett. 1999 Jun 1;106(2-3):237-46. Review.

PMID:
10403668

Supplemental Content

Support Center